{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-009584","form_type":"8-K","ticker":"FTLF","cik":"0001374328","company_name":"FITLIFE BRANDS, INC.","filed_at":"2025-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.462086+00:00","generated_at":"2026-05-24T03:48:07.733922+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"confidence":"high","headline":"FitLife Q4 rev +13% to $15M; FY24 adj EBITDA +39% to $14.1M; Q1 2025 rev seen -4-6%","bullets":["Q4 2024 revenue $15.0M (+13% YoY), net income $2.1M ($0.21 diluted EPS), adjusted EBITDA $3.1M (+31%).","FY24 revenue $64.5M (+22%), net income $9.0M (+70%), adj EBITDA $14.1M (+39%); net debt $8.6M (0.6x adj EBITDA).","GNC commercial dispute settled Jan 2025; Legacy FitLife Q4 wholesale down 20% due to order halt, now selling directly to franchisees.","MusclePharm Q4 revenue $2.8M (+14% seq); launched Pro Series at Vitamin Shoppe and new RTD protein; rebranding underway.","Q1 2025 prelim: revenue down 4-6% YoY (MRC seasonality, leap year), adj EBITDA flat; China tariffs may raise COGS, mitigating via raw material stockpiling."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-009584","json":"https://secwatch.observer/filing/0001437749-25-009584.json","markdown":"https://secwatch.observer/filing/0001437749-25-009584.md","text":"https://secwatch.observer/filing/0001437749-25-009584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374328/000143774925009584/0001437749-25-009584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374328/000143774925009584/ftlf20250327_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:48:07.733922+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}